Crown Bioscience
Crown Bioscience is a contract research & translational technology company making precision medicine a reality
News releases
-
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
Crown Bioscience announces a strategic partnership with Clinical Trial & Consulting Services (CTI), a renowned global full-spectrum research service provider, to bolster oncology-focused consulting...
-
Crown Bioscience Enters Global Agreement with Shanghai Model Organisms Center
Crown Bioscience announces the completion of a global collaboration agreement with the Shanghai Model Organism Center (SMOC). This five-year agreement extends the existing partnership and will prov...
-
Innovation Funding and Crown Bioscience: Collaborating to Discover the Next Wave of Oncology Therapies
Crown Bioscience has announced its pivotal role in several scientific innovation projects funded by European grants. These projects aim to advance cancer treatments and the development of the tools...
-
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
Crown Bioscience today announced the dual attainment of College of American Pathologists (CAP) accreditations for its medical laboratory services.
-
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
Crown Bioscience is set to display significant advances in preclinical and translational oncology research at a prominent cancer research meeting, AACR 2024. The company's contributions to the cont...
-
Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row
Crown Bioscience secures the T+ Employer® certification for healthcare excellence every year since the award was inaugurated in 2020.